GPX4 and breast cancer: Therefore, our study suggests that RUNX1-IT1 is a novel oncogenic lncRNA in breast cancer, dysregulation of RUNX1-IT1/IGF2BP1/GPX4 is responsible for breast cancer carcinogenesis and progression.